Australasia is a term variably used to describe a region of Oceania – namely Australia, New Zealand, and neighbouring islands in the Pacific Ocean.

The term was coined by Charles de Brosses in Histoire des navigations aux terres australes (1756). He derived it from the Latin for "south of Asia" and differentiated the area from Polynesia (to the east) and the southeast Pacific (Magellanica); it is also distinct from Micronesia (to the northeast).

Physical geography

---

Physiographically, Australasia includes the Australian landmass (including Tasmania), New Zealand, and Melanesia: New Guinea and neighbouring islands north and east of Australia in the Pacific Ocean. The designation is sometimes applied to all the lands and islands of the Pacific Ocean lying between the equator and latitude 47° south.

More on [ Australasia ]

Ernst & Young: United States RSS

QIS 3 to QIS 4: from consultation to implementation
webmaster@ey.com (Ernst & Young) Mon, 22 Sep 2008 15:57:22 -0400
The Committee of European Insurance and Occupational Pensions Supervisors (CEIOPS) is involving the insurance industry in a multi-year consultation process to test proposed Solvency II regulations. These Quantitative Impact Studies (QIS), performed by companies on a volunteer basis, test the design and calibration of the future European Standard formula.
SEC issues IFRS "Roadmap"
webmaster@ey.com (Ernst & Young) Mon, 15 Sep 2008 15:16:31 -0400
On 27 August the SEC approved for public comment a proposed "Roadmap" about the eventual use of IFRS by US companies. It anticipates mandatory reporting in 2014, 2015 or 2016, depending on the size of the issuer, and provides for early adoption in some cases. This Hot Topic summarizes the most significant aspects of the proposed Roadmap, based on comments made at the SEC's public meeting.
Theresa Harrison is Named to Network Journal’s "40 Under Forty"
webmaster@ey.com (Ernst & Young) Mon, 15 Sep 2008 15:11:12 -0400
Theresa Harrison, Director of Supplier Diversity, is one of this year's "40 Under Forty Dynamic Achievers,” according to Network Journal magazine. Co-chair of our Professional Women's Network, Theresa was honored for her career accomplishments and her commitment to her community. In addition to providing opportunities for diverse business owners, Theresa volunteers with the Selective Corporate Internship Program, which exposes talented high school juniors to prospective corporate careers.
Beth Brooke named one of world’s '100 Most Powerful Women' for the third year in a row
webmaster@ey.com (Ernst & Young) Mon, 15 Sep 2008 15:06:00 -0400
For the third consecutive year, Forbes magazine has named Beth Brooke, Ernst & Young Global Vice Chair of Public Policy, Sustainability and Stakeholder Engagement, to its prestigious list of the World’s 100 Most Powerful Women. Beth “balances a politician's passion with the scrupulous eye of a CPA,” Forbes noted.
The transformation of the tax landscape
webmaster@ey.com (Ernst & Young) Mon, 15 Sep 2008 15:02:39 -0400
Four change engines are reshaping how tax professionals operate and think about their roles, according to Mark Weinberger, Global Vice Chair of Tax. Globalization, a new tax audit paradigm, a shifting economy and impending legislative and regulatory developments bring extraordinary challenges and opportunities. Read Mark’s speech published in Tax Notes.
Webcast: Goodwill and long-lived assets in an IFRS world
webmaster@ey.com (Ernst & Young) Mon, 15 Sep 2008 14:59:12 -0400
Despite similarities between IFRS and US GAAP for accounting and impairment of long-lived assets, differences still exist. They are notable in the way impairment is reviewed, recognized and measured. We invite you to attend our IFRS webcast on 19 September so you can learn how to reduce risk and manage changes specific to recognition and impairment of goodwill, long-lived assets and intangibles.

CFDA: FDA Latest Warning Letters

WL Issued to Venosan North America
FDA Wed, 21 Nov 2007 00:00:00 -0400
FDA Warning Letter Issued to Venosan North America on 21 Nov 2007 by Center for Devices and Radiological Health
WL Issued to Ranbaxy Laboratories, Ltd., Dewas, India
FDA Tue, 16 Sep 2008 00:00:00 -0400
FDA Warning Letter Issued to Ranbaxy Laboratories, Ltd., Dewas, India on 16 Sep 2008 by Center for Drug Evaluation and Research
WL Issued to Ranbaxy Laboratories, Ltd., Paonta Sahib, India
FDA Tue, 16 Sep 2008 00:00:00 -0400
FDA Warning Letter Issued to Ranbaxy Laboratories, Ltd., Paonta Sahib, India on 16 Sep 2008 by Center for Drug Evaluation and Research

Subscribe to Consulting RSS feed